---
title: "Fosun Pharma unit Fosun Adgenvax files for Hong Kong IPO in proposed spin-off listing"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290957351.md"
description: "Fosun International has filed for the spin-off listing of its subsidiary, Fosun Adgenvax, on Hong Kong’s Main Board. The IPO application was submitted on June 26, 2026, for H shares. The offering size is expected to be up to 25% of the enlarged share capital, with a 15% over-allotment option. Fosun Adgenvax will remain under Fosun Pharma post-listing, and preferential allocation is planned for Fosun International shareholders, subject to regulatory approvals."
datetime: "2026-06-26T11:21:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290957351.md)
  - [en](https://longbridge.com/en/news/290957351.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290957351.md)
generator: "portal-rs"
---

# Fosun Pharma unit Fosun Adgenvax files for Hong Kong IPO in proposed spin-off listing

-   Fosun International filed for a spin-off listing of Fosun Adgenvax, a Fosun Pharma subsidiary, on Hong Kong’s Main Board. \* Fosun Adgenvax submitted its listing application on June 26, 2026 for listing and dealing in its H shares. \* IPO size is expected to be up to 25% of enlarged share capital, with a 15% over-allotment option. \* Fosun Adgenvax is expected to remain a Fosun Pharma unit following the listing. \* Preferential allocation for Fosun International shareholders is planned, subject to regulatory clearances including the CSRC and Hong Kong Exchange. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fosun International Limited published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260626-12218048), on June 26, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [00656.HK](https://longbridge.com/en/quote/00656.HK.md)
- [600196.CN](https://longbridge.com/en/quote/600196.CN.md)
- [02196.HK](https://longbridge.com/en/quote/02196.HK.md)

## Related News & Research

- [Fosun Pharma unit starts China Phase II trial of COPD drug candidate FXS7553](https://longbridge.com/en/news/295775012.md)
- [Citi Adds FOSUN INTL  to 30-day Upside Catalyst Watch](https://longbridge.com/en/news/294297255.md)
- [Rizhao Port Jurong schedules board meeting to review interim results, consider dividend](https://longbridge.com/en/news/296198168.md)
- [Tianjin Port Development sets board meeting to review interim results](https://longbridge.com/en/news/296082739.md)
- [Medtide schedules board meeting to review interim results](https://longbridge.com/en/news/296077044.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**